Vertex Pharmaceuticals target price cut to $660 from $665 by Morgan Stanley
VRTX•Morgan Stanley cut its target price for Vertex Pharmaceuticals to $660 from $665.
VRTX•VRTX•VRTX•Morgan Stanley cut its target price for Vertex Pharmaceuticals to $660 from $665.
